Early Phase II Clinical Study of TS-142 in Patients with Insomnia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223515

Enrollment

Registered

2017-04-25

Start date

2017-07-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

investigational material(s) Generic name etc : TS-142 INN of investigational material : - Therapeutic category code : 112 Hypnotics and sedatives, antianxietics Dosage and Administration for Investiga

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Diagnosis of insomnia disorder - Outpatient etc.

Exclusion criteria

Exclusion criteria: - Any lifetime diagnosis of others Sleep-Wake Disorder. - Serious hepatic disorder, renal disorder. etc.

Design outcomes

Primary

Measure	Time frame
efficacy latency to persistent sleep and wakefulness after sleep once by polysomnography(PSG)	—

Secondary

Measure	Time frame
efficacy Total Sleep Time by polysomnography	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026